Ahn-Gook Pharmaceutical Co. Ltd (001540) — Free Cash Flow Generation Index
Ahn-Gook Pharmaceutical Co. Ltd (001540) has a Free Cash Flow Generation Index of 0.81x as of September 2025. Free cash flow of ₩11.68 Billion represents 1% of operating cash flow (₩14.44 Billion). Explore Ahn-Gook Pharmaceutical Co. Ltd (001540) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Ahn-Gook Pharmaceutical Co. Ltd Free Cash Flow Generation Index (2012–2024)
Historical FCF Generation Index trend for Ahn-Gook Pharmaceutical Co. Ltd across 11 annual periods. For the full cash flow conversion analysis, see 001540 cash flow conversion.
Annual Free Cash Flow Generation for Ahn-Gook Pharmaceutical Co. Ltd (2012–2024)
Year-by-year Free Cash Flow Generation Index for Ahn-Gook Pharmaceutical Co. Ltd. Check Ahn-Gook Pharmaceutical Co. Ltd cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (KRW) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | -14.53x | ₩-71.39 Billion | ₩4.91 Billion | ₩75.89 Billion | ▼ -1205.7% |
| 2022 | -1.11x | ₩-1.99 Billion | ₩1.79 Billion | ₩2.93 Billion | ▲ +55.6% |
| 2021 | -2.51x | ₩-3.69 Billion | ₩1.47 Billion | ₩4.04 Billion | ▼ -110.9% |
| 2020 | -1.19x | ₩-13.30 Billion | ₩11.19 Billion | ₩24.12 Billion | ▼ -283.6% |
| 2019 | 0.65x | ₩14.29 Billion | ₩22.08 Billion | ₩3.74 Billion | ▼ -49.2% |
| 2017 | 1.27x | ₩22.26 Billion | ₩17.46 Billion | ₩4.79 Billion | ▼ -5.4% |
| 2016 | 1.35x | ₩17.00 Billion | ₩12.62 Billion | ₩4.38 Billion | ▲ +20.1% |
| 2015 | 1.12x | ₩21.44 Billion | ₩19.11 Billion | ₩2.33 Billion | ▼ -82.9% |
| 2014 | 6.56x | ₩8.44 Billion | ₩1.29 Billion | ₩7.16 Billion | ▲ +133.5% |
| 2013 | 2.81x | ₩10.24 Billion | ₩3.64 Billion | ₩6.60 Billion | ▲ +129.6% |
| 2012 | 1.22x | ₩14.09 Billion | ₩11.51 Billion | ₩2.58 Billion | — |